İsmail Doğan
- Immunology top 5%
- Rheumatology top 10%
- Spondyloarthritis Studies and Treatments 7
- Rheumatoid Arthritis Research and Therapies 7
- Systemic Lupus Erythematosus Research 6
- Pathology and Forensic Medicine top 10%
- Systemic Sclerosis and Related Diseases 5
- Nephrology top 10%
- Gout, Hyperuricemia, Uric Acid 4
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 4
-
- COVID-19 Clinical Research Studies 4
-
- Inflammasome and immune disorders 4
- Co-authors
- Jean–Claude WeillClaude–Agnès ReynaudFrédéric DelbosValérie VilmontSébastien StorckBarbara BertocciJérôme MegretKamil Kumanlıoğlu
- Journals
- Nuclear Medicine Communications (2 papers)Clinical Biochemistry (2 papers)Free Radical Biology and Medicine (1 paper)
- Partner nations
- TürkiyeUnited KingdomUnited States
In The Last Decade
İsmail Doğan
52 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 96
- Immunology 516
- Rheumatology 112
- Pathology and Forensic Medicine 130
- Endocrinology, Diabetes and Metabolism 119
- Nephrology 43
Countries citing papers authored by İsmail Doğan
This map shows the geographic impact of İsmail Doğan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by İsmail Doğan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites İsmail Doğan more than expected).
Fields of papers citing papers by İsmail Doğan
This network shows the impact of papers produced by İsmail Doğan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by İsmail Doğan. The network helps show where İsmail Doğan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside İsmail Doğan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 2 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 3 | |
| 7 | 2022 | 4 | |
| 8 | 2022 | 2 | |
| 9 | 2022 | 0 | |
| 10 | 2022 | 2 | |
| 11 | 2021 | 0 | |
| 12 | 2021 | 1 | |
| 13 | 2020 | 6 | |
| 14 | 2014 | 5 | |
| 15 | 2011 | 1 | |
| 16 | 2011 | 3 | |
| 17 | 2010 | 3 | |
| 18 | 2009 | 461 | |
| 19 | 2006 | 116 | |
| 20 | 2005 | 25 |
About İsmail Doğan
İsmail Doğan is a scholar working on Rheumatology, Nephrology, Biological Psychiatry, Pathology and Forensic Medicine and Immunology, having authored 60 papers that have together received 1.0k indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (7 papers), Rheumatoid Arthritis Research and Therapies (7 papers), Systemic Lupus Erythematosus Research (6 papers), Systemic Sclerosis and Related Diseases (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers), COVID-19 Clinical Research Studies (4 papers), Inflammasome and immune disorders (4 papers) and Gout, Hyperuricemia, Uric Acid (4 papers). The work is most often cited by research in Immunology (516 citations), Rheumatology (112 citations), Pathology and Forensic Medicine (130 citations), Endocrinology, Diabetes and Metabolism (119 citations) and Nephrology (43 citations). İsmail Doğan has collaborated with scholars based in Türkiye, United Kingdom and United States. Frequent co-authors include Jean–Claude Weill, Claude–Agnès Reynaud, Frédéric Delbos, Valérie Vilmont, Sébastien Storck, Barbara Bertocci, Jérôme Megret, Kamil Kumanlıoğlu, Sedat Kiraz and Levent Kılıç. Their work appears in journals such as Nuclear Medicine Communications, Clinical Biochemistry, Free Radical Biology and Medicine, Biomarkers in Medicine and Biomolecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.